AGA
Altrinsic Global Advisors Portfolio holdings
AUM
$2.76B
This Quarter Return
-10.13%
1 Year Return
+17.53%
3 Year Return
+48.92%
5 Year Return
+91.21%
10 Year Return
+153.34%
AUM
$2.09B
AUM Growth
+$2.09B
(-5.5%)
Cap. Flow
+$127M
Cap. Flow
% of AUM
6.09%
Top 10 Holdings %
Top 10 Hldgs %
56.09%
Holding
89
New
5
Increased
44
Reduced
14
Closed
7
Top Buys
| 1 |
Baidu
BIDU
|
$47.2M |
| 2 |
Willis Towers Watson
WTW
|
$30.9M |
| 3 |
Hartford Financial Services
HIG
|
$28.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
$27.3M |
| 5 |
Liberty Global Class A
LBTYA
|
$22.1M |
Top Sells
| 1 |
Medtronic
MDT
|
$50M |
| 2 |
ICICI Bank
IBN
|
$25.1M |
| 3 |
GE Aerospace
GE
|
$21.4M |
| 4 |
Advance Auto Parts
AAP
|
$12.6M |
| 5 |
Sabre
SABR
|
$10.3M |
Sector Composition
| 1 | Financials | 31.76% |
| 2 | Communication Services | 19.37% |
| 3 | Healthcare | 12.93% |
| 4 | Technology | 10.35% |
| 5 | Consumer Staples | 7.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
ProQR Therapeutics
PRQR
$255M
| $2.86M | 0.14% |
181,360
-10,000
| -5% | -$158K |
|
52
Brookdale Senior Living
BKD
$1.82B
| $2.7M | 0.13% |
402,452
| – | – |
|
53
Telefônica Brasil
VIV
$19.7B
| $2.53M | 0.12% |
212,255
| – | – |
|
|
AKCA
54
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $2.27M | 0.11% |
75,286
-20,000
| -21% | -$603K |
|
|
NUVA
55
DELISTED
NuVasive, Inc.
NUVA
| $1.98M | 0.1% |
40,000
| – | – |
|
56
Tenaris
TS
$18.3B
| $1.89M | 0.09% |
88,494
+27,005
| +44% | +$576K |
|
57
Loews
L
$20B
| $1.81M | 0.09% |
39,802
| – | – |
|
58
Voyager Therapeutics
VYGR
$207M
| $1.79M | 0.09% |
189,927
+10,000
| +6% | +$94K |
|
|
AAC
59
DELISTED
AAC Holdings, Inc.
AAC
| $1.64M | 0.08% |
1,174,370
+150,000
| +15% | +$210K |
|
60
Encompass Health
EHC
$12.4B
| $1.57M | 0.08% |
25,461
-2,735
| -10% | -$169K |
|
|
NBIS
61
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.7B
| $1.49M | 0.07% |
54,528
-929
| -2% | -$25.4K |
|
62
Kura Oncology
KURA
$719M
| $1.47M | 0.07% |
105,000
+25,000
| +31% | +$351K |
|
|
ARA
63
DELISTED
American Renal Associates Holdings, Inc
ARA
| $1.38M | 0.07% |
120,000
+20,000
| +20% | +$230K |
|
|
NVRO
64
DELISTED
NEVRO CORP.
NVRO
| $1.36M | 0.07% |
+35,000
| New | +$1.36M |
|
65
Cisco
CSCO
$268B
| $1.11M | 0.05% |
25,660
| – | – |
|
66
Shinhan Financial Group
SHG
$23.1B
| $1.09M | 0.05% |
30,669
+19,036
| +164% | +$676K |
|
67
Xenon Pharmaceuticals
XENE
$3B
| $947K | 0.05% |
150,000
+30,000
| +25% | +$189K |
|
68
Fate Therapeutics
FATE
$115M
| $898K | 0.04% |
70,000
| – | – |
|
|
DVCR
69
DELISTED
Diversicare Healthcare Services Inc
DVCR
| $886K | 0.04% |
373,952
| – | – |
|
70
NetEase
NTES
$85.6B
| $863K | 0.04% |
3,667
+1,275
| +53% | +$300K |
|
|
FPRX
71
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $837K | 0.04% |
90,000
| – | – |
|
|
ELGX
72
DELISTED
Endologix Inc
ELGX
| $813K | 0.04% |
1,135,000
| – | – |
|
73
Vipshop
VIPS
$8.35B
| $686K | 0.03% |
125,615
| – | – |
|
74
ZTO Express
ZTO
$14.5B
| $682K | 0.03% |
43,093
| – | – |
|
|
SURF
75
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $679K | 0.03% |
160,078
+10,078
| +7% | +$42.7K |
|